
Hua Jasmine Song
Examiner (ID: 5920, Phone: (571)272-4213 , Office: P/2133 )
| Most Active Art Unit | 2133 |
| Art Unit(s) | 2187, 2188, 2189, 2133, 2138, 2131 |
| Total Applications | 1406 |
| Issued Applications | 1267 |
| Pending Applications | 70 |
| Abandoned Applications | 80 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5508000
[patent_doc_number] => 20090081207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'High affinity human and humanized anti-alpha5beta1 integrin function blocking antibodies with reduced immunogenicity'
[patent_app_type] => utility
[patent_app_number] => 11/802573
[patent_app_country] => US
[patent_app_date] => 2007-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 9598
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081207.pdf
[firstpage_image] =>[orig_patent_app_number] => 11802573
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/802573 | High affinity human and humanized anti-alpha5beta1 integrin function blocking antibodies with reduced immunogenicity | May 22, 2007 | Abandoned |
Array
(
[id] => 4798021
[patent_doc_number] => 20080009607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'ANTIBODIES TO SULFATED CARBOHYDRATES'
[patent_app_type] => utility
[patent_app_number] => 11/751863
[patent_app_country] => US
[patent_app_date] => 2007-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13092
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20080009607.pdf
[firstpage_image] =>[orig_patent_app_number] => 11751863
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/751863 | Antibodies to sulfated carbohydrates | May 21, 2007 | Issued |
Array
(
[id] => 5230828
[patent_doc_number] => 20070292936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'BINDING POLYPEPTIDES WITH OPTIMIZED SCAFFOLDS'
[patent_app_type] => utility
[patent_app_number] => 11/745644
[patent_app_country] => US
[patent_app_date] => 2007-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 62
[patent_no_of_words] => 45794
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20070292936.pdf
[firstpage_image] =>[orig_patent_app_number] => 11745644
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/745644 | BINDING POLYPEPTIDES WITH OPTIMIZED SCAFFOLDS | May 7, 2007 | Abandoned |
Array
(
[id] => 4797133
[patent_doc_number] => 20080008719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'Methods and compositions for the treatment of prostate cancer'
[patent_app_type] => utility
[patent_app_number] => 11/789556
[patent_app_country] => US
[patent_app_date] => 2007-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 22136
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20080008719.pdf
[firstpage_image] =>[orig_patent_app_number] => 11789556
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/789556 | Methods and compositions for the treatment of prostate cancer | Apr 23, 2007 | Abandoned |
Array
(
[id] => 5379346
[patent_doc_number] => 20090191185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'Reducing Cancer Cell Invasion Using an Inhibitor of Toll Like Receptor Signaling'
[patent_app_type] => utility
[patent_app_number] => 12/298469
[patent_app_country] => US
[patent_app_date] => 2007-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 14573
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20090191185.pdf
[firstpage_image] =>[orig_patent_app_number] => 12298469
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/298469 | Reducing Cancer Cell Invasion Using an Inhibitor of Toll Like Receptor Signaling | Apr 12, 2007 | Abandoned |
Array
(
[id] => 5552741
[patent_doc_number] => 20090286727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'DP-78-Like Nanobodies'
[patent_app_type] => utility
[patent_app_number] => 12/226173
[patent_app_country] => US
[patent_app_date] => 2007-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 35157
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20090286727.pdf
[firstpage_image] =>[orig_patent_app_number] => 12226173
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/226173 | DP-78-Like Nanobodies | Apr 11, 2007 | Abandoned |
Array
(
[id] => 5230286
[patent_doc_number] => 20070292393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'USE OF THYMOSIN ALPHA 1 FOR PREPARING A MEDICAMENT FOR THE TREATMENT OF STAGE IV MALIGNANT MELANOMA'
[patent_app_type] => utility
[patent_app_number] => 11/734592
[patent_app_country] => US
[patent_app_date] => 2007-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3591
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20070292393.pdf
[firstpage_image] =>[orig_patent_app_number] => 11734592
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/734592 | Use of thymosin alpha 1 for preparing a medicament for the treatment of stage IV malignant melanoma | Apr 11, 2007 | Issued |
Array
(
[id] => 5125442
[patent_doc_number] => 20070237713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'PCan065 Antibody Compositions and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 11/696442
[patent_app_country] => US
[patent_app_date] => 2007-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 44216
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20070237713.pdf
[firstpage_image] =>[orig_patent_app_number] => 11696442
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/696442 | PCan065 Antibody Compositions and Methods of Use | Apr 3, 2007 | Abandoned |
Array
(
[id] => 5177048
[patent_doc_number] => 20070178108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-02
[patent_title] => 'Colon Specific Gene and Protein and Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/696199
[patent_app_country] => US
[patent_app_date] => 2007-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 78570
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20070178108.pdf
[firstpage_image] =>[orig_patent_app_number] => 11696199
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/696199 | Colon Specific Gene and Protein and Cancer | Apr 3, 2007 | Abandoned |
Array
(
[id] => 5091659
[patent_doc_number] => 20070231298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'Cytokine-expressing cancer immunotherapy combinations'
[patent_app_type] => utility
[patent_app_number] => 11/728660
[patent_app_country] => US
[patent_app_date] => 2007-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15260
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0231/20070231298.pdf
[firstpage_image] =>[orig_patent_app_number] => 11728660
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/728660 | Cytokine-expressing cancer immunotherapy combinations | Mar 26, 2007 | Abandoned |
Array
(
[id] => 4657186
[patent_doc_number] => 20080026047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Cancer Detection Reagents And Uses In Pathology And Diagnostics And Cancer Cell Death'
[patent_app_type] => utility
[patent_app_number] => 11/690638
[patent_app_country] => US
[patent_app_date] => 2007-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6591
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20080026047.pdf
[firstpage_image] =>[orig_patent_app_number] => 11690638
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/690638 | Cancer Detection Reagents And Uses In Pathology And Diagnostics And Cancer Cell Death | Mar 22, 2007 | Abandoned |
Array
(
[id] => 5165583
[patent_doc_number] => 20070287170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-13
[patent_title] => 'Engineered heterodimeric protein domains'
[patent_app_type] => utility
[patent_app_number] => 11/728048
[patent_app_country] => US
[patent_app_date] => 2007-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 16514
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20070287170.pdf
[firstpage_image] =>[orig_patent_app_number] => 11728048
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/728048 | Engineered heterodimeric protein domains | Mar 22, 2007 | Issued |
Array
(
[id] => 8189606
[patent_doc_number] => 08183347
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-22
[patent_title] => 'Anti-TAT226 antibodies and immunoconjugates'
[patent_app_type] => utility
[patent_app_number] => 11/687309
[patent_app_country] => US
[patent_app_date] => 2007-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 54404
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/183/08183347.pdf
[firstpage_image] =>[orig_patent_app_number] => 11687309
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/687309 | Anti-TAT226 antibodies and immunoconjugates | Mar 15, 2007 | Issued |
Array
(
[id] => 5125509
[patent_doc_number] => 20070237780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'Method of preventing or reducing the risk or incidence of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/684736
[patent_app_country] => US
[patent_app_date] => 2007-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13047
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20070237780.pdf
[firstpage_image] =>[orig_patent_app_number] => 11684736
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/684736 | Method of preventing or reducing the risk or incidence of cancer | Mar 11, 2007 | Abandoned |
Array
(
[id] => 5131111
[patent_doc_number] => 20070207508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-06
[patent_title] => 'METHOD AND ASSAY KIT FOR SIMULTANEOUSLY DETECTING MULTIPLE TUMOR MARKERS WITH INTERFERENCE INDICATION'
[patent_app_type] => utility
[patent_app_number] => 11/682141
[patent_app_country] => US
[patent_app_date] => 2007-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12131
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20070207508.pdf
[firstpage_image] =>[orig_patent_app_number] => 11682141
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/682141 | METHOD AND ASSAY KIT FOR SIMULTANEOUSLY DETECTING MULTIPLE TUMOR MARKERS WITH INTERFERENCE INDICATION | Mar 4, 2007 | Abandoned |
Array
(
[id] => 5005023
[patent_doc_number] => 20070202593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Cell-Targeted IKB and Methods for the Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/679630
[patent_app_country] => US
[patent_app_date] => 2007-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19627
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20070202593.pdf
[firstpage_image] =>[orig_patent_app_number] => 11679630
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/679630 | Cell-Targeted IKB and Methods for the Use Thereof | Feb 26, 2007 | Abandoned |
Array
(
[id] => 5004545
[patent_doc_number] => 20070202113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Cytotoxicity mediation of cells evidencing surface expression of TROP-2'
[patent_app_type] => utility
[patent_app_number] => 11/709676
[patent_app_country] => US
[patent_app_date] => 2007-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 32483
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20070202113.pdf
[firstpage_image] =>[orig_patent_app_number] => 11709676
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/709676 | Cytotoxicity mediation of cells evidencing surface expression of TROP-2 | Feb 21, 2007 | Issued |
Array
(
[id] => 5004475
[patent_doc_number] => 20070202043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Cytotoxicity mediation of cells evidencing surface expression of TROP-2'
[patent_app_type] => utility
[patent_app_number] => 11/709898
[patent_app_country] => US
[patent_app_date] => 2007-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 29320
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20070202043.pdf
[firstpage_image] =>[orig_patent_app_number] => 11709898
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/709898 | Cytotoxicity mediation of cells evidencing surface expression of TROP-2 | Feb 21, 2007 | Issued |
Array
(
[id] => 5379372
[patent_doc_number] => 20090191211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'METHODS FOR DAMAGING CELLS USING EFFECTOR FUNCTIONS OF ANTI-EphA4 ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 12/280950
[patent_app_country] => US
[patent_app_date] => 2007-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15172
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20090191211.pdf
[firstpage_image] =>[orig_patent_app_number] => 12280950
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/280950 | Methods for damaging cells using effector functions of anti-EphA4 antibodies | Feb 21, 2007 | Issued |
Array
(
[id] => 5354678
[patent_doc_number] => 20090186022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-23
[patent_title] => 'Organic Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/280674
[patent_app_country] => US
[patent_app_date] => 2007-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 29982
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20090186022.pdf
[firstpage_image] =>[orig_patent_app_number] => 12280674
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/280674 | Organic compounds | Feb 20, 2007 | Issued |